Description
MIR Spirobank® Smart
300 million people suffer from asthma, over 200 million people worldwide have COPD
Lung function reduces much before the symptoms occur, preventing patients from becoming aware of their pathology.
Prevention is essential.
MIR Spirobank®Smart is ideal for monitoring respiratory illness and in the self management of Asthma, COPD, Lung Trasplants care, Cystic Fibrosis and for use in Clinical Trials.
Available with both DISPOSABLE or REUSABLE single patient turbine flowmeter
Spirometry test:
PEF, FVC, FEV1, FEV1/FVC Ratio, FEV6, FEF 25/75%
